Register

Please register so we can remember your preferences, like your favourite suppliers and preferred news & events.


Supplier Login



New user? Register as a supplier


Forgot password?


My Account

Aerie Pharmaceuticals appoints Barry Ivin as Site Director of new manufacturing plant in Ireland

Aerie Pharmaceuticals, a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, has appointed Barry Ivin as Site Director of Aerie’s new manufacturing plant in Athlone, Ireland.

Aerie Pharmaceuticals appoints Barry Ivin as Site Director of new manufacturing plant in Ireland

On 9 January 2017, Aerie entered into a lease agreement with Ireland’s Industrial Development Agency for the Athlone site.

Mr Ivin will be responsible for leadership and direction over the build-out and validation of the plant and, if Aerie receives regulatory approval, future manufacturing operations for commercial product supply.

He has significant site leadership and engineering experience, and was most recently employed by Genzyme Ireland Limited (Sanofi), Waterford.

Mr Ivin holds a Chemical Engineering undergraduate degree from University of South Wales and a Masters of Business Administration from the Graduate School of Business, University College Dublin.

Read More

Read more

Categories

Market News

Other news in “Market News”

FlyPharma Conference: Collaboration is the Key

FlyPharma Conference: "Collaboration is the Key" 

16 Jun 2017
BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

BMS to sell manufacturing facility in Swords, Ireland to SK Biotek 

16 Jun 2017
FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus

FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus 

15 Jun 2017

Are you a supplier? Here's what we can do for you

Register now